In 2017, Venteicher et al. [137] combined scRNA-seq profiles from astrocytoma (IDH-A) and oligodendroglioma (IDH-O) tumors with 165 TCGA bulk RNA-seq profiles to analyze their genotype, phenotype, and the TME. The gene discussed is IDH2; the disease is astrocytoma (excluding glioblastoma).